Français ISMP (US) Feedback
    Search: 
   
 
 
 
Webinar
 
 
 

Improving the safety of ambulatory IV chemotherapy in Canada:
Results and recommendations from a 2–year exploratory study

March 30, 2011 (at 12 noon ET)

The death of a patient due to a fluorouracil overdose, and other similar incidents, highlighted the risks of ambulatory IV chemotherapy. As a follow–up to the root cause analysis of the event, a two–year research project was funded by a number of cancer and safety agencies across Canada. The objectives were to identify safety issues in ambulatory IV chemotherapy in a wide range of environments.

This one hour webinar will highlight the results and recommendations from the two–year pan–Canadian exploratory study on safety issues in ambulatory intravenous chemotherapy.

Learning Objectives:

At the conclusion of this webinar, participants will be able to:

  • Describe the rationale and overall approach to the study
  • List 3–4 themes of safety issues identified in the research
  • Identify areas of improvement in their own chemotherapy delivery processes

Audience: Physicians, nurses, pharmacists, technicians and administrators involved in chemotherapy or other high–risk medication delivery.

Date: March 30, 2011

Time: 9:00 am – 10:00 am PT
10:00 am – 11:00 am MT
11:00 am – 12:00 pm CT
12:00 pm – 1:00 pm ET
1:00 pm – 2:00 pm AT
1:30 pm – 2:30 pm NT

Duration: 1 hour

Cost: • Webinar only $49 (per telephone connection plus applicable HST/GST)1
• Webinar plus DVD $98 (per telephone connection plus applicable HST/GST)1
• DVD only $49 + (plus applicable HST/GST)1

1This is a discounted rate. Support from University Health Network and the Canadian Association of Provincial Cancer Agencies
to provide this webinar is greatly appreciated and has made reduced registration fees possible.


For registration information, please select the Registration’ tab near the top of the screen.

Presenters: Rachel White, Human Factors Specialist, University Health Network, and

Venetia Bourrier, Director, Provincial Oncology Drug Program, CancerCare Manitoba

Contact Us: webinars@ismp–canada.org

Registration

Three Easy Ways to Register

Online: All major credit cards are accepted by PayPal. Fill in the form below and click the Buy Now button to go to the PayPal website to complete the transaction.


First Name:
  Last Name:
  
Position:
  Email:
(for registration confirmation)
Organization:
Street:
City:
Country:
Province/State:
Postal/Zip Code:
Total:
$95.00 (plus applicable taxes)
For the total including tax, please select your country and province/state above.
   

Fax: Complete this pdf form and fax to 416-733-1146 with credit card information..
     

Mail: Complete this pdf form and mail together with cheque or credit card information to:

       ISMP Canada
       Medication Safety Learning Centre
       4711 Yonge Street
       (Procter and Gamble building)
       Toronto, Ontario
       M2N 6K8

Confirmation
Registration will be confirmed within 10 days of receipt of payment.

Cancellation Policy
Notice of all cancellations must be provided in writing at least 7 days prior to the event. A $75 administration fee will apply to all refunds. There are no refunds for registrants who cancel after the cancellation deadline.

Registrants may postpone attendance to a future workshop however a $75 administration fee will apply if notice of postponement is received less than 7 days prior to the event.

ISMP Canada reserves the right to cancel or reschedule workshops. In the event of a cancellation, fees paid will be credited towards a future workshop, or fully refunded.

For additional information, call 1-866-544-7672 ext. 0 (416-733-3131 ext.0) or email to education@ismpcanada.ca
     

Speakers

Rachel White, M.A.
Human Factors Specialist, Health Technology Safety Research Team, University Health Network, Toronto

Rachel is passionate about making healthcare safer for patients by making environments, processes and technologies more intuitive for clinicians. She has a keen interest in integrating human factors principles into medication safety initiatives, especially those relating to chemotherapy. Through her research on independent double checking of high–risk clinical procedures, and the study Improving the Safety of Ambulatory IV Chemotherapy in Canada, she has gained a strong understanding and respect for the role that clinicians, especially pharmacists and nurses, play in patient safety.

A graduate of Carleton University in Ottawa, Rachel received an MA in Psychology, specializing in Human–Computer Interaction, from the Human–Oriented Technology Lab (HOTLab).

 

Venetia Bourrier, BSc., B.Sc. Pharm., FCSHP
Director of Provincial Oncology Drug Program, CancerCare Manitoba

Venetia received her Bachelor of Science degree in Pharmacy from the University of Manitoba in 1985 and a Bachelor of Science in Molecular Biology form the University of Winnipeg in 1981. She is a member of the Canadian Society of Hospital Pharmacists (CSHP), the Manitoba Pharmaceutical Association (MPhA) and the Systemic Therapy Safety Committee of the Canadian Association of Provincial Cancer Agencies (CAPCA). From 2004 to 2008 she acted on the planning committee for the National Oncology Pharmacy Symposium (NOPS). In 2004 she was the recipient of CSHP Fellow Status and CSHP Manitoba Branch Merck Frosst Achievement award. From 2002 to 2004 she was President of Manitoba Association of Pharmacy and was on the task force to develop and review oncology pharmacy practice standards. In 2002 and 2003 she was Chief Administrator for the Pharmacy Examining Board of Canada (PEBC) Qualifying Examination Part II OSCE. Venetia also participates on several advisory boards on oncology topics.

Background

Related Links:

ISMP Canada Safety Bulletins:


Additional Information:

Contact Us

Mail:
ISMP Canada
4711 Yonge Street, Suite 501
Toronto, ON M2N 6K8
Email:
webinars@ismp-canada.org
Phone:
416–733–3131 ext.0
Toll Free:
1–866–544–7672 ext.0
Fax:
416–733–1146